Reacting to numerous requests, we present you pill reports in this issue. Some years ago, the scientific analysis of party drugs used to be a regular feature in mushroom magazine. We used to present the data form Germany’s party organization DROBS Hanover. Since this service is not available any more, we now present you recent information from the Swiss organization saferparty.ch. Keep in mind, that names, stamps and shapes of pills are often copied and that the correctness of these reports can not be guaranteed.
m-CPP being sold as XTC These pills being sold as XTC do not contain MDMA but a rather high dosage of the piperazine m-CPP. For some persons, this substance provokes a MDMA-like effect (rather hallucinogen, less entactogen, which is to say emotional and social). Many persons report no primary effect at all but only side-effects. If the expected MDMA effect does not occur and pconsumers take more of these pills, the risk is given of a very high dosage m-CPP. Also, some of these pills include domperidone and metoclopramide. Nothing is known about the interaction of these substances!
XTC with caffeine Beside MDMA, this pill also contains caffeine. The combination of these two substances can intensify their effects and means a high chemical body burden.
High-dose XTCs These pills contain more than 120 mg of MDMA which might be too much. High dosages of MDMA provoke side-effects like ‘jaw-grinding’, fluttering eyelids and nerves or even attacks of sudden cramps. Also, an overdose will make the body temperature rise stronger and it might provoke hallucinations.
4-FA being sold as XTC This pill being sold as XTC does not contain MDMA but a high dosage of 4-flouramphetamine. Even if the effect might be comparable to that of MDMA in some respects, 4-FA is a research chemical. Few, if anything is known about its effects and side-effects. Consumers of this substance take an incalculable risk.